| scholarly article | Q13442814 |
| P50 | author | Benedikt M. Kessler | Q30504197 |
| Gethin Thomas | Q56234751 | ||
| Paul Bowness | Q56942640 | ||
| Matthew A. Brown | Q37371767 | ||
| Roman Fischer | Q42035488 | ||
| P2093 | author name string | Linda A Bradbury | |
| David C Trudgian | |||
| Cynthia Wright | |||
| P2860 | cites work | Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1 | Q27667473 |
| Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming | Q27667505 | ||
| Linear models and empirical bayes methods for assessing differential expression in microarray experiments | Q27860758 | ||
| Acute-phase proteins and other systemic responses to inflammation | Q28296941 | ||
| Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D | Q28749552 | ||
| THE LASSO METHOD FOR VARIABLE SELECTION IN THE COX MODEL | Q29038535 | ||
| Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility | Q29417082 | ||
| A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids | Q29547337 | ||
| METLIN: a metabolite mass spectral database | Q29614808 | ||
| Statistical Issues in cDNA Microarray Data Analysis | Q30788312 | ||
| Bioactive analogs that simulate subsets of biological activities of 1alpha,25(OH)(2)D(3) in osteoblasts. | Q31943517 | ||
| Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides | Q33322989 | ||
| Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series. | Q51842574 | ||
| Resolution of Inflammation Following Treatment of Ankylosing Spondylitis Is Associated with New Bone Formation | Q61540566 | ||
| Isolation and identification of 25-hydroxyvitamin D3-26,23-peroxylactone. A novel in vivo metabolite of vitamin D3 | Q67246292 | ||
| A new role for corticosteroid binding globulin (CBG), member of SERPIN superfamily | Q67895467 | ||
| Isolation and identification of 1 alpha,25-dihydroxy-24-oxovitamin D3, 1 alpha,25-dihydroxyvitamin D3 26,23-lactone, and 1 alpha,24(S),25-trihydroxyvitamin D3: in vivo metabolites of 1 alpha,25-dihydroxyvitamin D3 | Q70812821 | ||
| Protein SAP (serum amyloid P-component) in Waldenström's macroglobulinaemia, multiple myeloma and rheumatic diseases | Q71625021 | ||
| 1alpha,25-dihydroxyvitamin D(3)-26,23-lactone analogs antagonize differentiation of human leukemia cells (HL-60 cells) but not of human acute promyelocytic leukemia cells (NB4 cells) | Q73139112 | ||
| Antithrombin acts as a negative acute phase protein as established with studies on HepG2 cells and in baboons | Q73727711 | ||
| The SHAP-HA complex in sera from patients with rheumatoid arthritis and osteoarthritis | Q77919284 | ||
| A rapid, economical, and reproducible method for human serum delipidation and albumin and IgG removal for proteomic analysis | Q79436508 | ||
| Classification criteria for rheumatoid arthritis and ankylosing spondylitis | Q84703410 | ||
| Interleukin-1 is essential for systemic inflammatory bone loss | Q33406072 | ||
| Bioinformatics analysis of microarray data | Q33504701 | ||
| Increased expression of carbonic anhydrase I in the synovium of patients with ankylosing spondylitis | Q33766861 | ||
| Kallistatin inhibits vascular inflammation by antagonizing tumor necrosis factor-alpha-induced nuclear factor kappaB activation | Q34070667 | ||
| Anti-cyclic citrullinated peptide versus anti-Sa antibodies in diagnosis of rheumatoid arthritis in an outpatient clinic for connective tissue disease and spondyloarthritis. | Q34553111 | ||
| Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity | Q34739582 | ||
| 23,25-Dihydroxyvitamin D3: a natural precursor in the biosynthesis of 25-hydroxyvitamin D3-26,23-lactone. | Q35455140 | ||
| Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction | Q35554235 | ||
| Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays | Q35751704 | ||
| The inflammation-induced down-regulation of plasma Fetuin-A ( 2HS-Glycoprotein) in liver results from the loss of interaction between long C/EBP isoforms at two neighbouring binding sites | Q36372808 | ||
| Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. | Q36376473 | ||
| Diagnosing ankylosing spondylitis | Q36623890 | ||
| Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis | Q36993283 | ||
| Investigating the genetic association between ERAP1 and ankylosing spondylitis | Q37378130 | ||
| New tools for diagnosing spondyloarthropathy | Q37691904 | ||
| Genetics and genomics of ankylosing spondylitis | Q37700800 | ||
| Pathogenesis of ankylosing spondylitis. | Q37762157 | ||
| Genomics of ankylosing spondylitis. | Q37793435 | ||
| 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis | Q37871699 | ||
| Spondyloarthritis | Q37891477 | ||
| ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors | Q38491419 | ||
| Novel multiplex technology for diagnostic characterization of rheumatoid arthritis | Q39186261 | ||
| Structures and biological activities of vitamin D metabolites and their analogs | Q39666967 | ||
| SHAP potentiates the CD44-mediated leukocyte adhesion to the hyaluronan substratum. | Q40279635 | ||
| Serum paraoxonase after myocardial infarction | Q40824784 | ||
| Serum amyloid P-component is an acute-phase reactant in the mouse | Q41461262 | ||
| Complement activation and complement control proteins in acute pancreatitis | Q41817327 | ||
| Molecular cloning and expression of rat kallistatin gene | Q42666163 | ||
| Proteomic analysis of circulating immune complexes in juvenile idiopathic arthritis reveals disease-associated proteins | Q42784768 | ||
| Over-expression of talin 1 and integrin-linked kinase in PBMCs of patients with ankylosing spondylitis: a proteomic study. | Q42788782 | ||
| Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs/coxibs' treatment effect on C-reactive protein | Q43211465 | ||
| Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis | Q43887189 | ||
| Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis | Q46711906 | ||
| Upregulation of kallistatin expression in rheumatoid joints. | Q46950091 | ||
| Serum MMP-3 level as a biomarker for monitoring and predicting response to etanercept treatment in ankylosing spondylitis. | Q51455735 | ||
| Gene expression profiling reveals a downregulation in immune-associated genes in patients with AS. | Q51807375 | ||
| P4510 | describes a project that uses | limma | Q112236343 |
| P433 | issue | 2 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | M111.013904 | |
| P577 | publication date | 2011-10-13 | |
| P1433 | published in | Molecular & Cellular Proteomics | Q6895932 |
| P1476 | title | Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis | |
| P478 | volume | 11 |
| Q37356331 | A multilectin affinity approach for comparative glycoprotein profiling of rheumatoid arthritis and spondyloarthropathy. |
| Q47421750 | Analysis of the plasma proteome using iTRAQ and TMT-based Isobaric labeling |
| Q33640595 | Ankylosing spondylitis in iran; late diagnosis and its causes. |
| Q24305116 | Arginine methylation controls growth regulation by E2F-1 |
| Q96817691 | Biomarker development for axial spondyloarthritis |
| Q37199564 | Cell metabolomics |
| Q35476632 | Cells deficient in base-excision repair reveal cancer hallmarks originating from adjustments to genetic instability |
| Q34772586 | Change in IgG1 Fc N-linked glycosylation in human lung cancer: age- and sex-related diagnostic potential |
| Q57671022 | Characterization of ankylosing spondylitis and rheumatoid arthritis using 1H NMR-based metabolomics of human fecal extracts |
| Q90638475 | Circulating Retinol-Binding Protein 4 as a Possible Biomarker of Treatment Response for Ankylosing Spondylitis: An Array-Based Comparative Study |
| Q39026274 | Critical role of endoplasmic reticulum aminopeptidase 1 in determining the length and sequence of peptides bound and presented by HLA-B27. |
| Q64906378 | Elucidating the endogenous synovial fluid proteome and peptidome of inflammatory arthritis using label-free mass spectrometry. |
| Q35152006 | Genetic control of differential acetylation in diabetic rats |
| Q55332100 | Global transcriptome analysis to identify critical genes involved in the pathology of osteoarthritis. |
| Q35273295 | Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways |
| Q36508139 | Identification and validation of urinary metabolite biomarkers for major depressive disorder |
| Q36056195 | Identification of 7 Proteins in Sera of RA Patients with Potential to Predict ETA/MTX Treatment Response. |
| Q39760969 | Identification of distinct circulating exosomes in Parkinson's disease |
| Q35061614 | Identification of potential transcriptomic markers in developing ankylosing spondylitis: a meta-analysis of gene expression profiles |
| Q36474376 | KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands. |
| Q35799972 | Liquid phase based separation systems for depletion, prefractionation, and enrichment of proteins in biological fluids and matrices for in-depth proteomics analysis-An update covering the period 2011-2014. |
| Q28382957 | Mass spectrometry-based methods for identifying oxidized proteins in disease: advances and challenges |
| Q26765005 | Metabolomics in rheumatic diseases: desperately seeking biomarkers |
| Q54767965 | Metabolomics in rheumatology. |
| Q39028575 | PCNA dependent cellular activities tolerate dramatic perturbations in PCNA client interactions |
| Q37286747 | Plasma degradome affected by variable storage of human blood |
| Q92099371 | Proteomic Profiling for Serum Biomarkers in Mice Exposed to Ionizing Radiation |
| Q57726311 | Proteomic profiling of the plasma of Gambian children with cerebral malaria |
| Q93155997 | Proteomics Approach for the Discovery of Rheumatoid Arthritis Biomarkers Using Mass Spectrometry |
| Q35253379 | Serum fatty acid profiles and potential biomarkers of ankylosing spondylitis determined by gas chromatography-mass spectrometry and multivariate statistical analysis |
| Q45886414 | Serum protein profile of Crohn's disease treated with infliximab |
| Q33614561 | Social defeat stress causes depression-like behavior with metabolite changes in the prefrontal cortex of rats |
| Q97652867 | Systemic lipid dysregulation is a risk factor for macular neurodegenerative disease |
| Q90170116 | TEX264 coordinates p97- and SPRTN-mediated resolution of topoisomerase 1-DNA adducts |
| Q38569186 | The ASAS Criteria for Axial Spondyloarthritis: Strengths, Weaknesses, and Proposals for a Way Forward |
| Q57178714 | The Jumonji-C oxygenase JMJD7 catalyzes (3S)-lysyl hydroxylation of TRAFAC GTPases |
| Q38106620 | The role of vitamin D supplementation in patients with rheumatic diseases |
| Q34693456 | Two birds with one stone: doing metabolomics with your proteomics kit. |
| Q35389974 | Vitamin D Status Affects Serum Metabolomic Profiles in Pregnant Adolescents |
| Q38262855 | Vitamin D and spondyloarthritis |
Search more.